About HORIBA
HORIBA is a company based in Kyoto (Japan) founded in 1945 by Masao Horiba. The company has 8,960 employees as of December 31, 2024. HORIBA has completed 7 acquisitions, including Aist-Nt, BeXema and Etamax. HORIBA offers products and services including Raman Spectroscopy, ICP-OES, and Glow Discharge Optical Emission Spectroscopy. HORIBA operates in a competitive market with competitors including Quotient Biodiagnostics, Boule Diagnostics, Entia, FYR Diagnostics and Mursla, among others.
- Headquarter Kyoto, Japan
- Employees 8960 as on 31 Dec, 2024
- Founders Masao Horiba
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Horiba , Ltd.
-
Annual Revenue
$2.02 B (USD)9.23as on Dec 31, 2024
-
Net Profit
$214 M (USD)-16.65as on Dec 31, 2024
-
EBITDA
$391.18 M (USD)2.5as on Dec 31, 2024
-
Latest Funding Round
$407.3 K (USD), Grant
Sep 01, 2022
- Investors
-
Employee Count
8960
as on Dec 31, 2024
-
Investments & Acquisitions
Aist-Nt
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HORIBA
HORIBA is a publicly listed company on the TSE with ticker symbol 6856 in Japan, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of HORIBA
HORIBA offers a comprehensive portfolio of products and services, including Raman Spectroscopy, ICP-OES, and Glow Discharge Optical Emission Spectroscopy.
Analyzes molecular vibrations for material and life science applications.
Detects elements in samples for research and industrial testing.
Measures material composition for semiconductor and metals.
People of HORIBA
Unlock access to complete
Funding Insights of HORIBA
Investors in HORIBA
HORIBA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for HORIBA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HORIBA
HORIBA has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Aist-Nt, BeXema and Etamax.
Investment portfolio details for HORIBA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
High-performance battery storage services are provided in the energy sector.
|
Locked | Locked | 2014 | Locked | |
|
Nanoparticle characterization devices are designed and manufactured by MANTA Instruments.
|
Locked | Locked | 2014 | Locked | |
|
HORIBA is engaged in designing and distributing in vitro diagnostic systems.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for HORIBA
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - HORIBA
Detailed financials for HORIBA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Horiba Comparisons
Peer comparison for HORIBA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HORIBA
HORIBA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quotient Biodiagnostics, Boule Diagnostics, Entia, FYR Diagnostics and Mursla, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of immunohematology products for use in transfusion diagnostics
|
|
| Locked | Locked | Locked |
Provider of blood count analyzer for human and veterinary applications
|
|
| Locked | Locked | Locked |
Point-of-care devices for blood analysis are developed and provided.
|
|
| Locked | Locked | Locked |
In-vitro diagnostic tests for disease detection are provided.
|
|
| Locked | Locked | Locked |
Diagnostic devices for cancer detection are developed using nanostructures.
|
Detailed competitors of HORIBA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Horiba
Complete news archive for HORIBA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HORIBA
HORIBA was founded in 1945 and raised its 1st funding round 68 years after it was founded.
HORIBA is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
As of Dec 31, 2024, the latest employee count at HORIBA is 8,960.
Annual revenue of HORIBA is $2.02B as on Dec 31, 2024.
HORIBA provides a wide range of measurement solutions for applications ranging from automotive RD, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific RD and QC measurements. The HORIBA medical system is focused on products related to hematology (hematology platform including reticulocytes by fluorescence, bench-top analyzer, Veterinary hematology testing analyzer).
HORIBA's top competitors include Quotient Biodiagnostics, Entia and Boule Diagnostics.
HORIBA offers Raman Spectroscopy, ICP-OES, and Glow Discharge Optical Emission Spectroscopy.
Yes, HORIBA is publicly traded on TSE under the ticker symbol 6856.
HORIBA has 1 investor. Key investors include European Union.
The ticker symbol of HORIBA is 6856 on TSE.